Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease
✍ Scribed by D. Merims; H. Shabtai; A. D. Korczyn; C. Peretz; N. Weizman; N. Giladi
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 90 KB
- Volume
- 111
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract To determine whether the risk factors for dementia in idiopathic Parkinson's disease (IPD) are similar to the risk factors for Alzheimer's disease, we conducted a case‐control study of potential risk factors. A structured interview as was administered to surrogates of 17 demented subjec
## Abstract An association between mutations in the __glucocerebrosidase__ (__GBA__) gene and Parkinson's disease (PD) has been reported in several populations. We searched for four common __GBA__ mutations (L444P, F213I, R353W, and N370S) in 402 Chinese PD patients and 413 age‐ and sex‐matched con